1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Blast to plasmacytoid dendritic cell ratio is predictive of progression in low grade myelodysplastic syndromes
    Meeting Abstract

    Chan, A.; Lewis, N.; Baik, J.; Arcila, M.; Zhang, Y.; Klimek, V.; Roshal, M.; Xiao, W.
    Laboratory Investigation (2019)

    Fulltext@MSK | Save
  • Application of CAR T cells for the treatment of solid tumors
    Journal Article

    Khan, J. F.; Khan, A. S.; Brentjens, R. J.
    Progress in Molecular Biology and Translational Science (2019)

    Fulltext@MSK | Save
  • Current treatment of esophageal cancer and promising clinical trials underway [Interview]
    Journal Article

    Ku, G. Y.
    Oncology (Norwalk) (2019)

    Fulltext@MSK | Save
  • Ibrutinib-rituximab or chemoimmunotherapy for chronic lymphocytic leukemia
    Journal Article

    Shanafelt, T. D.; Wang, X. V.; Kay, N. E.; Hanson, C. A.; O'Brien, S.; Barrientos, J.; Jelinek, D. F.; Braggio, E.; Leis, J. F.; Zhang, C. C.; more...
    New England Journal of Medicine (2019)

    Fulltext@MSK | Save
  • Will GALEN become more RELEVANT?
    Editorial

    von Keudell, G.; Younes, A.
    The Lancet Haematology (2019)

    Fulltext@MSK | Save
  • CD33 splice site genotype was not associated with outcomes of patients receiving the anti-CD33 drug conjugate SGN-CD33A
    Research Letter

    Stanchina, M.; Pastore, A.; Devlin, S.; Famulare, C.; Stein, E.; Taylor, J.
    Journal of Hematology & Oncology (2019)

    Fulltext@MSK | Save
  • Dose-adjusted EPOCH-R compared with R-CHOP as frontline therapy for diffuse large B-cell lymphoma: Clinical outcomes of the phase III intergroup trial alliance/CALGB 50303
    Journal Article

    Bartlett, N. L.; Wilson, W. H.; Jung, S. H.; Hsi, E. D.; Maurer, M. J.; Pederson, L. D.; Polley, M. Y. C.; Pitcher, B. N.; Cheson, B. D.; Kahl, B. S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Measurement of the DNA alkylating agents busulfan and melphalan in human plasma by mass spectrometry
    Journal Article

    Schofield, R. C.; Landau, H. J.; Giralt, S. A.; Shah, G. L.; Scordo, M.; Lin, A.; Zanutto, E.; Ramanathan, L. V.; Pessin, M. S.; Carlow, D. C.
    Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences (2019)

    Fulltext@MSK | Save
  • Noncovalent inhibitors reveal BTK gatekeeper and auto-inhibitory residues that control its transforming activity
    Journal Article

    Wang, S.; Mondal, S.; Zhao, C.; Berishaj, M.; Ghanakota, P.; Batlevi, C. L.; Dogan, A.; Seshan, V. E.; Abel, R.; Green, M. R.; more...
    JCI Insight (2019)

    Fulltext@MSK | Save
  • T cell receptor-based cancer immunotherapy: Emerging efficacy and pathways of resistance
    Review

    Chandran, S. S.; Klebanoff, C. A.
    Immunological Reviews (2019)

    Fulltext@MSK | Save